Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Photos: The annual Peeps chick drop rang in the new year early Wednesday night during PeepsFest in Bethlehem. An Allentown man is accused of shattering the doors to the federal courthouse, causing ...
Some were public leaders; others were stalwarts in business, education, medicine, religion and other areas. The year’s list also included a world-renowned broadcast journalist, a Morning Call ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback